Placental Growth Factor as a Novel Marker in Uremia-Related Cardiovascular Disease

Publisher： Karger

E-ISSN： 1421-9670|42|2|115-116

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.42, Iss.2, 2015-0, pp. : 115-116

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Prognostic Impact of Placental Growth Factor on Mortality and Cardiovascular Events in Dialysis Patients

By  

American Journal of Nephrology, Vol. 42, Iss. 2, 2015-0 ,pp. : 117-125

Karger

Access to resources Recommend Favorite

Novel Aspects of Transforming Growth Factor-Beta in Diabetic Kidney Disease

By  

Nephron, Vol. 92, Iss. 1, 2002-08 ,pp. : 7-21

Karger

Access to resources Recommend Favorite

Fibroblast Growth Factor 23 and Matrix-Metalloproteinases in Patients with Chronic Kidney Disease: Are They Associated with Cardiovascular Disease?

By  

Kidney and Blood Pressure Research, Vol. 32, Iss. 4, 2009-10 ,pp. : 276-283

Karger

Access to resources Recommend Favorite

Vascular Disease and Atherosclerosis in Uremia

By  

Blood Purification, Vol. 19, Iss. 2, 2000-12 ,pp. : 139-142

Karger

Access to resources Recommend Favorite

Is Fibroblast Growth Factor 23 the New Biomarker for Cardiovascular Mortality in Chronic Kidney Disease Patients?

By  

American Journal of Nephrology, Vol. 45, Iss. 2, 2016-12 ,pp. : 146-148

Karger

Access to resources Recommend Favorite